A Dose-Escalating Pilot Study (NCT03017404) of Pegylated Liposomal Doxorubicin and Cyclophosphamide, Followed by Docetaxel Administration as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer

Advanced Breast Cancer ◽

Liposomal Doxorubicin ◽

Chemotherapy Regimen ◽

Locally Advanced ◽

Dose Escalating

Neoadjuvant chemotherapy with a combination of pegylated liposomal doxorubicin (Caelyx®) and paclitaxel in locally advanced breast cancer: a phase II study by the Hellenic Cooperative Oncology Group

Annals of Oncology ◽

10.1093/annonc/mdf284 ◽

2002 ◽

Vol 13 (11) ◽

pp. 1737-1742 ◽

Cited By ~ 46

Author(s):

H. Gogas ◽

C. Papadimitriou ◽

H.P. Kalofonos ◽

D. Bafaloukos ◽

G. Fountzilas ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Locally Advanced ◽

Oncology Group

Neoadjuvant chemotherapy with low dose of pegylated liposomal doxorubicin plus weekly paclitaxel in operable and locally advanced breast cancer

Anti-Cancer Drugs ◽

10.1097/cad.0b013e3283043585 ◽

2008 ◽

Vol 19 (7) ◽

pp. 733-737 ◽

Cited By ~ 18

Author(s):

David Rossi ◽

Anna Maria Baldelli ◽

Virginia Casadei ◽

Stefano Luzi Fedeli ◽

Paolo Alessandroni ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Low Dose ◽

Liposomal Doxorubicin ◽

Locally Advanced ◽

Advanced Breast ◽

Weekly Paclitaxel

P1-12-25: Evaluation of PTEN, EGFR and Ki67 Expression as Predictors of Response to a Trastuzumab-Containing Neoadjuvant Chemotherapy Regimen in a HER-2 Over-Expressing Locally Advanced Breast Cancer (LABC) Trial.

10.1158/0008-5472.sabcs11-p1-12-25 ◽

2011 ◽

Author(s):

J Ho ◽

G Turashvili ◽

M Hayes ◽

KA Gelmon ◽

SL Ellard ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Chemotherapy Regimen ◽

Locally Advanced ◽

Advanced Breast ◽

Ki67 Expression ◽

Predictors Of Response ◽

Her 2

Pegylated liposomal doxorubicin in combination with low-dose metronomic cyclophosphamide as preoperative treatment for patients with locally advanced breast cancer

The Breast ◽

10.1016/j.breast.2011.02.014 ◽

2011 ◽

Vol 20 (4) ◽

pp. 319-323 ◽

Cited By ~ 26

Author(s):

Silvia Dellapasqua ◽

Manuelita Mazza ◽

Debora Rosa ◽

Raffaella Ghisini ◽

Eloise Scarano ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Low Dose ◽

Liposomal Doxorubicin ◽

Locally Advanced ◽

Advanced Breast ◽

Preoperative Treatment ◽

Metronomic Cyclophosphamide

Phase II study of neoadjuvant gemcitabine (GC), pegylated liposomal doxorubicin (DX) and docetaxel (TT) in locally advanced breast cancer

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.606 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 606-606

Author(s):

G. Cartei ◽

L. Borgato ◽

G. Lombardi ◽

A. Cappetta ◽

F. Bozza ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Locally Advanced ◽

Evaluation of PTEN, EGFR, and Ki67 expression as predictors of response to a trastuzumab-containing neoadjuvant chemotherapy regimen in a HER2 overexpressing locally advanced breast cancer (LABC) trial.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e11029 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e11029-e11029

Author(s):

J. Ho ◽

G. Turashvili ◽

M. Hayes ◽

K. A. Gelmon ◽

S. Ellard ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Chemotherapy Regimen ◽

Locally Advanced ◽

Advanced Breast ◽

Ki67 Expression ◽

Predictors Of Response

Neoadjuvant Chemotherapy of Locally Advanced Breast Cancer: Predicting Response with in Vivo1H MR Spectroscopy—A Pilot Study at 4 T

Radiology ◽

10.1148/radiol.2332031285 ◽

2004 ◽

Vol 233 (2) ◽

pp. 424-431 ◽

Cited By ~ 242

Author(s):

Sina Meisamy ◽

Patrick J. Bolan ◽

Eva H. Baker ◽

Robin L. Bliss ◽

Evin Gulbahce ◽

...

Keyword(s):

Breast Cancer ◽

Pilot Study ◽

Advanced Breast Cancer ◽

Mr Spectroscopy ◽

Locally Advanced ◽

434 Phase II Study of Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/− Trastuzumab Followed by Docetaxel in Locally Advanced Breast Cancer (LABC)

European Journal of Cancer ◽

10.1016/s0959-8049(12)70500-2 ◽

2012 ◽

Vol 48 ◽

pp. S173

Author(s):

M.K. Tuxen ◽

S. Cold ◽

U.B. Tange ◽

S.B. Soendergaard ◽

D.L. Nielsen

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Locally Advanced ◽

A regimen with low-dose pegylated liposomal doxorubicin plus paclitaxel is active in operable and locally advanced breast cancer,

Inpharma Weekly ◽

10.2165/00128413-200816500-00048 ◽

2008 ◽

Vol &NA; (1650) ◽

pp. 14

Author(s):

&NA;

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Low Dose ◽

Liposomal Doxorubicin ◽

Locally Advanced ◽

4–12 Neoadjuvant Chemotherapy of Locally Advanced Breast Cancer: Predicting Response With in Vivo 1H MR Spectroscopy—A Pilot Study at 4 T1

Breast Diseases A Year Book Quarterly ◽

10.1016/s1043-321x(05)80271-1 ◽

2006 ◽

Vol 16 (4) ◽

pp. 341-342

Author(s):

R.E. Hendrick

Keyword(s):

Breast Cancer ◽

Pilot Study ◽

Advanced Breast Cancer ◽

Mr Spectroscopy ◽

Locally Advanced ◽

Advanced Breast ◽

1H Mr Spectroscopy